Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Rix Brooks

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 9, 2014
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2012
Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohortMaya Abdelnour-Mallet, Sophie Tezenas Du Montcel, Pamela A Cazzolli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Muscle & Nerve|January 9, 2019
Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosisGary L Pattee, Emily K Plowman, Kendrea L Focht Garand, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 9, 2014
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2012
Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohortMaya Abdelnour-Mallet, Sophie Tezenas Du Montcel, Pamela A Cazzolli, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Muscle & Nerve|January 9, 2019
Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosisGary L Pattee, Emily K Plowman, Kendrea L Focht Garand, et al.
Pageof 5